Company Filing History:
1 out of 832,880 Years Active: 1999
Title: Marja-Terttu Matikainen: Innovator in Monoclonal Antibodies
Introduction
Marja-Terttu Matikainen is a prominent inventor known for her significant contributions to the field of biotechnology. She is based in Mynamaki, Finland, and has made notable advancements in the development of monoclonal antibodies. Her work focuses on innovative solutions for diagnosing and treating diseases associated with angiogenesis.
Latest Patents
Marja-Terttu Matikainen holds a patent for an invention titled "Antibodies recognizing tie receptor tyrosine kinase and uses thereof." This patent describes an anti-Tie monoclonal antibody, 3C4C7G6, which serves as a diagnostic tool for detecting angiogenesis related to neoplasia, wound healing, and various other angiogenesis-associated diseases. Additionally, the disclosed antibody is valuable for radiological imaging of blood vessels and can be utilized as a therapeutic agent.
Career Highlights
Throughout her career, Marja-Terttu Matikainen has demonstrated a commitment to advancing medical science through her research and inventions. Her work has the potential to impact the diagnosis and treatment of critical health conditions, showcasing her dedication to improving patient outcomes.
Collaborations
Marja-Terttu Matikainen has collaborated with esteemed colleagues in her field, including Kari Alitalo and Juha Partanen. These partnerships have contributed to the success and development of her innovative research.
Conclusion
Marja-Terttu Matikainen is a trailblazer in the field of monoclonal antibodies, with her patent offering promising applications in diagnostics and therapeutics. Her contributions continue to influence the landscape of medical research and innovation.